Search Results - Franovic, Aleksandra

Human cancers converge at the HIF-2α oncogenic axis by Franovic, Aleksandra, Holterman, Chet E., Payette, Josianne, Lee, Stephen

Get full text Get full text Get full text

Urine test for EGFR analysis in patients with non-small cell lung cancer by Franovic, Aleksandra, Raymond, Victoria M., Erlander, Mark G., Reckamp, Karen L.

Get full text Get full text Get full text

Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer by Franovic, Aleksandra, Gunaratnam, Lakshman, Smith, Karlene, Robert, Isabelle, Patten, David, Lee, Stephen

Get full text Get full text Get full text

DNMT3a epigenetic program regulates the HIF-2α oxygen-sensing pathway and the cellular response to hypoxia by Lachance, Gabriel, Uniacke, James, Audas, Timothy E., Holterman, Chet E., Franovic, Aleksandra, Payette, Josianne, Lee, Stephen

Get full text Get full text Get full text

Integrin αvβ3 Drives Slug Activation and Stemness in the Pregnant and Neoplastic Mammary Gland by Desgrosellier, Jay S, Lesperance, Jacqueline, Seguin, Laetitia, Gozo, Maricel, Kato, Shumei, Franovic, Aleksandra, Yebra, Mayra, Shattil, Sanford J, Cheresh, David A

Get full text Get full text Get full text

Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort by Lee, Jeeyun, Franovic, Aleksandra, Shiotsu, Yukimasa, Kim, Seung Tae, Kim, Kyoung-Mee, Banks, Kimberly C., Raymond, Victoria M., Lanman, Richard B.

Get full text Get full text Get full text

An oxygen-regulated switch in the protein synthesis machinery by Uniacke, James, Holterman, Chet E., Lachance, Gabriel, Franovic, Aleksandra, Jacob, Mathieu D., Fabian, Marc R., Payette, Josianne, Holcik, Martin, Pause, Arnim, Lee, Stephen

Get full text Get full text Get full text

A MEK-independent role for CRAF in mitosis and tumor progression by Mielgo, Ainhoa, Seguin, Laetitia, Huang, Miller, Camargo, Maria Fernanda, Anand, Sudarshan, Franovic, Aleksandra, Weis, Sara M., Advani, Sunil J., Murphy, Eric A., Cheresh, David A.

Get full text Get full text Get full text

Kinase-independent role for CRAF-driving tumour radioresistance via CHK2 by Advani, Sunil J., Camargo, Maria Fernanda, Seguin, Laetitia, Mielgo, Ainhoa, Anand, Sudarshan, Hicks, Angel M., Aguilera, Joseph, Franovic, Aleksandra, Weis, Sara M., Cheresh, David A.

Get full text Get full text Get full text

Antitumor Activity of RXDX-105 in Multiple Cancer Types with RET Rearrangements or Mutations by Li, Gang G., Somwar, Romel, Joseph, James, Smith, Roger S., Hayashi, Takuo, Martin, Leenus, Franovic, Aleksandra, Schairer, Anni, Martin, Eric, Riely, Gregory J., Harris, Jason, Yan, Shunqi, Wei, Ge, Oliver, Jennifer W., Patel, Rupal, Multani, Pratik, Ladanyi, Marc, Drilon, Alexander

Get full text Get full text Get full text

MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment by Wilson, RaeAnna, Espinosa-Diez, Cristina, Kanner, Nathan, Chatterjee, Namita, Ruhl, Rebecca, Hipfinger, Christina, Advani, Sunil J., Li, Jie, Khan, Omar F., Franovic, Aleksandra, Weis, Sara M., Kumar, Sushil, Coussens, Lisa M., Anderson, Daniel G., Chen, Clark C., Cheresh, David A., Anand, Sudarshan

Get full text Get full text Get full text

A β3 integrin-KRAS-RalB complex drives tumor stemness and resistance to EGFR inhibition by Seguin, Laetitia, Kato, Shumei, Franovic, Aleksandra, Camargo, M. Fernanda, Lesperance, Jacqueline, Elliott, Kathryn C., Yebra, Mayra, Mielgo, Ainhoa, Lowy, Andrew M., Husain, Hatim, Cascone, Tina, Diao, Lixia, Wang, Jing, Wistuba, Ignacio I., Heymach, John V., Lippman, Scott M., Desgrosellier, Jay S., Anand, Sudarshan, Weis, Sara M., Cheresh, David A.

Get full text Get full text Get full text

Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia by DiNardo, Courtney D., Stein, Anthony S., Stein, Eytan M., Fathi, Amir T., Frankfurt, Olga, Schuh, Andre C., Döhner, Hartmut, Martinelli, Giovanni, Patel, Prapti A., Raffoux, Emmanuel, Tan, Peter, Zeidan, Amer M., de Botton, Stéphane, Kantarjian, Hagop M., Stone, Richard M., Frattini, Mark G., Lersch, Frederik, Gong, Jing, Gianolio, Diego A., Zhang, Vickie, Franovic, Aleksandra, Fan, Bin, Goldwasser, Meredith, Daigle, Scott, Choe, Sung, Wu, Bin, Winkler, Thomas, Vyas, Paresh

Get full text Get full text Get full text

Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study by Stein, Eytan M., DiNardo, Courtney D., Fathi, Amir T., Mims, Alice S., Pratz, Keith W., Savona, Michael R., Stein, Anthony S., Stone, Richard M., Winer, Eric S., Seet, Christopher S., Döhner, Hartmut, Pollyea, Daniel A., McCloskey, James K., Odenike, Olatoyosi, Löwenberg, Bob, Ossenkoppele, Gert J., Patel, Prapti A., Roshal, Mikhail, Frattini, Mark G., Lersch, Frederik, Franovic, Aleksandra, Nabhan, Salah, Fan, Bin, Choe, Sung, Wang, Hongfang, Wu, Bin, Hua, Lei, Almon, Caroline, Cooper, Michael, Kantarjian, Hagop M., Tallman, Martin S.

Get full text Get full text Get full text